Verwendun von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
申请人:BAYER AG
公开号:EP0728481A2
公开(公告)日:1996-08-28
Die vorliegende Erfindung betrifft die Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen.
A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME
申请人:New River Pharmaceuticals Inc.
公开号:EP1357928A2
公开(公告)日:2003-11-05
EP1357928A4
申请人:——
公开号:EP1357928A4
公开(公告)日:2004-12-29
COMBINATION OF IMMUNOMODULATOR AND ANTI-PATHOGENIC AGENT
申请人:Nunes, Iseu Da Silva
公开号:EP2259799B1
公开(公告)日:2014-03-12
Combination of Immunomodulator and Anti-Pathogenic Agent
申请人:Nunes Iseu da Silva
公开号:US20110028385A1
公开(公告)日:2011-02-03
A compound comprising combination of an immunomodulator and to at least one anti-pathogenic agent for treating of facultative or strict infections caused by intracellular microorganisms, the components of the combination or association of substances of the invention, the immunomodulator (proteic aggregate of ammonium and magnesium phospholinoleate-palmitoleate anhydride) and at least one substance with antimicrobial properties can be administered either jointly, simultaneously, consecutively or sequentially, in an appropriate form, according to their chemical properties, and in a dose effective against microorganisms in human and animals.